Cimzia 200 mg (Certolizumab Pegol SOLUTION) 200 MG

CIMZIA 200 MG is a subcutaneous solution containing certolizumab pegol, used for managing inflammatory conditions. This medication is designed to help reduce symptoms and improve quality of life for eligible patients.

Strength

200 MG

Pack Size

1ML

Manufacturer / TM Owner

UCB CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CIMZIA 200 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the body to reduce inflammation. Patients often wonder, 'What is CIMZIA used for?' This medication is prescribed to help manage symptoms and slow the progression of these conditions.

Side Effects

Common effects of CIMZIA 200 MG may include injection site reactions, upper respiratory infections, and mild gastrointestinal issues. Some users report feeling fatigued or experiencing mild headaches. These effects vary among individuals and are not experienced by everyone who uses the medication.

Precautions & Warnings

CIMZIA 200 MG should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to use it as directed. Patients should be aware of potential allergic reactions and seek medical advice if they experience severe side effects.

Avoid Interactions

CIMZIA 200 MG may interact with other medications, including those that suppress the immune system. It is important to inform a healthcare provider about all current medications before starting treatment. Alcohol and certain supplements may also interact with this medication, so patients should discuss their full health profile with a healthcare professional.

References

Frequently Asked Questions

CIMZIA 200 MG is used to manage symptoms of inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

CIMZIA 200 MG is administered subcutaneously, typically by injection. Patients should follow the instructions provided by their healthcare professional.

Common side effects may include injection site reactions, upper respiratory infections, and mild gastrointestinal issues.

CIMZIA 200 MG may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

CIMZIA 200 MG should be stored according to the instructions provided, typically in a refrigerator or at room temperature, away from light and moisture.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.